Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

2.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

3.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

4.

Never in a million years did I think I'd have to limit my chemotherapy.

5.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot